Cargando…
Pulmonary flow profile and distensibility following acute pulmonary embolism
OBJECTIVE: Proof of concept study evaluating CMR as screening tool for chronic thromboembolic pulmonary hypertension (CTEPH) in patients treated for acute pulmonary embolism (PE). MATERIALS AND METHODS: Right and left ventricular function of 15 consecutive patients treated for PE and 10 consecutive...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055838/ https://www.ncbi.nlm.nih.gov/pubmed/21332981 http://dx.doi.org/10.1186/1532-429X-13-14 |
_version_ | 1782200147437944832 |
---|---|
author | Klok, Frederikus A Romeih, Soha Westenberg, Jos JM Kroft, Lucia JM Huisman, Menno V de Roos, Albert |
author_facet | Klok, Frederikus A Romeih, Soha Westenberg, Jos JM Kroft, Lucia JM Huisman, Menno V de Roos, Albert |
author_sort | Klok, Frederikus A |
collection | PubMed |
description | OBJECTIVE: Proof of concept study evaluating CMR as screening tool for chronic thromboembolic pulmonary hypertension (CTEPH) in patients treated for acute pulmonary embolism (PE). MATERIALS AND METHODS: Right and left ventricular function of 15 consecutive patients treated for PE and 10 consecutive patients in whom PE was excluded was estimated at baseline by cardiac CT and at 6 months follow-up by CMR. Additionally, during the follow-up visit, pulmonary artery (PA) hemodynamics were studied by CMR and the presence of pulmonary hypertension by echocardiography. RESULTS: CT measured right ventricular ejection fraction (RVEF) was lower in patients with PE compared to patients without PE at time of diagnosis (median 47%, interquartile range 39-53 vs. 55%, 52-58; p = 0.014). After 6 months follow up, the RVEF between patients treated for PE and patients without PE were not statistically significant different (55%, 52-60 versus 54%, 51-57; p = 0.57), as were distensibility index (0.18 ± 0.18 versus 0.25 ± 0.18, p = 0.20), mean velocity (14.1 ± 3.9 cm/s versus 14.0 ± 2.5 cm/s, p = 0.81), peak velocity (86.5 ± 22 cm/s versus 89.6 ± 13 cm/s, p = 0.43) and time to peak PA blood flow velocity (142 ± 49 ms versus 161 ± 29 ms, p = 0.14). One patient was diagnosed with CTEPH and CMR revealed poor right systolic function, decreased PA distensibility and flow velocity, and a systolic notch in the PA flow profile consistent with persistent PA obstruction. CONCLUSION: In this small series, right ventricular performance and PA flow profiles of patients treated for 6 months after PE are equivalent to those parameters in normal patients. |
format | Text |
id | pubmed-3055838 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30558382011-03-12 Pulmonary flow profile and distensibility following acute pulmonary embolism Klok, Frederikus A Romeih, Soha Westenberg, Jos JM Kroft, Lucia JM Huisman, Menno V de Roos, Albert J Cardiovasc Magn Reson Research OBJECTIVE: Proof of concept study evaluating CMR as screening tool for chronic thromboembolic pulmonary hypertension (CTEPH) in patients treated for acute pulmonary embolism (PE). MATERIALS AND METHODS: Right and left ventricular function of 15 consecutive patients treated for PE and 10 consecutive patients in whom PE was excluded was estimated at baseline by cardiac CT and at 6 months follow-up by CMR. Additionally, during the follow-up visit, pulmonary artery (PA) hemodynamics were studied by CMR and the presence of pulmonary hypertension by echocardiography. RESULTS: CT measured right ventricular ejection fraction (RVEF) was lower in patients with PE compared to patients without PE at time of diagnosis (median 47%, interquartile range 39-53 vs. 55%, 52-58; p = 0.014). After 6 months follow up, the RVEF between patients treated for PE and patients without PE were not statistically significant different (55%, 52-60 versus 54%, 51-57; p = 0.57), as were distensibility index (0.18 ± 0.18 versus 0.25 ± 0.18, p = 0.20), mean velocity (14.1 ± 3.9 cm/s versus 14.0 ± 2.5 cm/s, p = 0.81), peak velocity (86.5 ± 22 cm/s versus 89.6 ± 13 cm/s, p = 0.43) and time to peak PA blood flow velocity (142 ± 49 ms versus 161 ± 29 ms, p = 0.14). One patient was diagnosed with CTEPH and CMR revealed poor right systolic function, decreased PA distensibility and flow velocity, and a systolic notch in the PA flow profile consistent with persistent PA obstruction. CONCLUSION: In this small series, right ventricular performance and PA flow profiles of patients treated for 6 months after PE are equivalent to those parameters in normal patients. BioMed Central 2011-02-18 /pmc/articles/PMC3055838/ /pubmed/21332981 http://dx.doi.org/10.1186/1532-429X-13-14 Text en Copyright ©2011 Klok et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Klok, Frederikus A Romeih, Soha Westenberg, Jos JM Kroft, Lucia JM Huisman, Menno V de Roos, Albert Pulmonary flow profile and distensibility following acute pulmonary embolism |
title | Pulmonary flow profile and distensibility following acute pulmonary embolism |
title_full | Pulmonary flow profile and distensibility following acute pulmonary embolism |
title_fullStr | Pulmonary flow profile and distensibility following acute pulmonary embolism |
title_full_unstemmed | Pulmonary flow profile and distensibility following acute pulmonary embolism |
title_short | Pulmonary flow profile and distensibility following acute pulmonary embolism |
title_sort | pulmonary flow profile and distensibility following acute pulmonary embolism |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055838/ https://www.ncbi.nlm.nih.gov/pubmed/21332981 http://dx.doi.org/10.1186/1532-429X-13-14 |
work_keys_str_mv | AT klokfrederikusa pulmonaryflowprofileanddistensibilityfollowingacutepulmonaryembolism AT romeihsoha pulmonaryflowprofileanddistensibilityfollowingacutepulmonaryembolism AT westenbergjosjm pulmonaryflowprofileanddistensibilityfollowingacutepulmonaryembolism AT kroftluciajm pulmonaryflowprofileanddistensibilityfollowingacutepulmonaryembolism AT huismanmennov pulmonaryflowprofileanddistensibilityfollowingacutepulmonaryembolism AT deroosalbert pulmonaryflowprofileanddistensibilityfollowingacutepulmonaryembolism |